These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3379756)

  • 1. [Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].
    Miyauchi A
    Gan No Rinsho; 1988 May; 34(6):739-43. PubMed ID: 3379756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Maeda M
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):102-8. PubMed ID: 3821708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
    Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
    Gautvik KM
    Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    World J Surg; 1988 Oct; 12(5):610-5. PubMed ID: 3245215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
    Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H
    Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary thyroid carcinoma--familial or sporadic disease?].
    Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medullary carcinoma of the thyroid: a clinical contribution].
    Angeli G; Brazzarola P; Bottura D; Bonomo S; Castellini C; Moser A; Vicenzi L; Mazzola F; Rizzo S; Betresini B; Ballarin A; Rosa G
    Chir Ital; 2002; 54(1):25-9. PubMed ID: 11942005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.